Free Trial

DocuSign, Inc. (NASDAQ:DOCU) Sees Significant Increase in Short Interest

DocuSign logo with Business Services background

DocuSign, Inc. (NASDAQ:DOCU - Get Free Report) was the target of a large increase in short interest in October. As of October 15th, there was short interest totalling 15,390,000 shares, an increase of 62.9% from the September 30th total of 9,450,000 shares. Based on an average daily volume of 3,080,000 shares, the days-to-cover ratio is currently 5.0 days.

Insider Activity

In related news, CEO Allan C. Thygesen sold 7,725 shares of the business's stock in a transaction dated Thursday, August 1st. The stock was sold at an average price of $54.89, for a total value of $424,025.25. Following the completion of the sale, the chief executive officer now directly owns 109,918 shares of the company's stock, valued at $6,033,399.02. The trade was a 0.00 % decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this link. In other news, Director Teresa Briggs sold 534 shares of the firm's stock in a transaction dated Monday, September 16th. The shares were sold at an average price of $56.56, for a total value of $30,203.04. Following the transaction, the director now directly owns 7,202 shares in the company, valued at approximately $407,345.12. This trade represents a 0.00 % decrease in their position. The transaction was disclosed in a filing with the SEC, which can be accessed through the SEC website. Also, CEO Allan C. Thygesen sold 7,725 shares of DocuSign stock in a transaction dated Thursday, August 1st. The shares were sold at an average price of $54.89, for a total transaction of $424,025.25. Following the completion of the transaction, the chief executive officer now directly owns 109,918 shares of the company's stock, valued at $6,033,399.02. This trade represents a 0.00 % decrease in their ownership of the stock. The disclosure for this sale can be found here. In the last 90 days, insiders have sold 427,554 shares of company stock worth $23,129,150. 1.66% of the stock is currently owned by corporate insiders.

Institutional Investors Weigh In On DocuSign

A number of hedge funds and other institutional investors have recently modified their holdings of DOCU. Massmutual Trust Co. FSB ADV grew its holdings in DocuSign by 5,000.0% during the second quarter. Massmutual Trust Co. FSB ADV now owns 510 shares of the company's stock worth $27,000 after acquiring an additional 500 shares during the period. Mather Group LLC. grew its holdings in DocuSign by 4,338.5% during the second quarter. Mather Group LLC. now owns 577 shares of the company's stock worth $31,000 after acquiring an additional 564 shares during the period. Register Financial Advisors LLC acquired a new position in DocuSign during the first quarter worth about $37,000. nVerses Capital LLC acquired a new position in DocuSign during the second quarter worth about $48,000. Finally, Quarry LP acquired a new position in DocuSign during the second quarter worth about $53,000. 77.64% of the stock is currently owned by institutional investors.

Analysts Set New Price Targets

A number of brokerages have commented on DOCU. Bank of America lifted their target price on DocuSign from $60.00 to $68.00 and gave the company a "neutral" rating in a research note on Friday, September 6th. Citigroup upped their price objective on DocuSign from $86.00 to $87.00 and gave the stock a "buy" rating in a research note on Friday, September 6th. Robert W. Baird raised their target price on DocuSign from $55.00 to $59.00 and gave the company a "neutral" rating in a research note on Friday, September 6th. JMP Securities reiterated a "market outperform" rating and issued a $84.00 target price on shares of DocuSign in a research note on Thursday, September 5th. Finally, Wells Fargo & Company raised their target price on DocuSign from $48.00 to $50.00 and gave the company an "underweight" rating in a research note on Friday, September 6th. Two analysts have rated the stock with a sell rating, seven have assigned a hold rating and two have issued a buy rating to the stock. According to MarketBeat, the company has an average rating of "Hold" and an average target price of $63.40.

View Our Latest Research Report on DOCU

DocuSign Price Performance

Shares of NASDAQ DOCU traded down $1.59 during midday trading on Friday, reaching $68.99. 2,564,023 shares of the company traded hands, compared to its average volume of 2,933,302. DocuSign has a 52 week low of $38.11 and a 52 week high of $73.80. The stock has a 50-day moving average price of $61.87 and a 200 day moving average price of $57.64. The company has a market cap of $14.12 billion, a price-to-earnings ratio of 132.67, a PEG ratio of 7.33 and a beta of 0.92.

DocuSign (NASDAQ:DOCU - Get Free Report) last issued its quarterly earnings data on Thursday, September 5th. The company reported $0.97 earnings per share for the quarter, beating analysts' consensus estimates of $0.80 by $0.17. DocuSign had a net margin of 34.56% and a return on equity of 16.18%. The business had revenue of $736.03 million for the quarter, compared to analysts' expectations of $727.20 million. During the same period in the previous year, the business earned $0.09 earnings per share. The company's revenue was up 7.0% on a year-over-year basis. As a group, analysts expect that DocuSign will post 1.01 EPS for the current year.

DocuSign Company Profile

(Get Free Report)

DocuSign, Inc provides electronic signature solution in the United States and internationally. The company provides e-signature solution that enables sending and signing of agreements on various devices; Contract Lifecycle Management (CLM), which automates workflows across the entire agreement process; Document Generation streamlines the process of generating new, custom agreements; and Gen for Salesforce, which allows sales representatives to automatically generate agreements with a few clicks from within Salesforce.

Featured Stories

Should you invest $1,000 in DocuSign right now?

Before you consider DocuSign, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and DocuSign wasn't on the list.

While DocuSign currently has a "Hold" rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 Stocks to Sell Now Cover

MarketBeat has just released its list of 20 stocks that Wall Street analysts hate. These companies may appear to have good fundamentals, but top analysts smell something seriously rotten. Are any of these companies lurking around your portfolio? Find out by clicking the link below.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

’Best Report in 2 Years’: NVIDIA Earnings Crushes Expectations Again
Palantir and the NASDAQ 100: What’s the Next Big Stock Swing for This AI Giant?
Rocket Lab Stock Explodes Higher—What’s Next for This Space Pioneer?

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines